Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices
Conclusions: Our results suggest that an elevation of PS+ microparticle levels may be associated with adverse clinical events. Thus, measuring PS+ microparticle levels in LVAD-supported patients may help identify patients at increased risk for adverse events.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Angelo Nascimbene, Ruben Hernandez, Joggy K. George, Anita Parker, Angela L. Bergeron, Subhashree Pradhan, K. Vinod Vijayan, Andrew Civitello, Leo Simpson, Maria Nawrot, Vei-Vei Lee, Hari R. Mallidi, Reynolds M. Delgado, Jing Fei Dong, O.H. Frazier Tags: Featured Articles Source Type: research
More News: Bleeding | Cardiology | Gastroenterology | Heart | Heart Attack | Heart Transplant | Hematology | Lung Transplant | Stroke | Study | Thrombosis | Transplant Surgery | Transplants | Ventricular Tachycardia